Redx About us Our pipeline Our science Investors News & events Contact us Discovering targeted medicines Redx is a biotech company focused on the discovery and development of novel targeted medicines for the treatment of cancer and fibrotic disease. About us Our pipeline RXC004 (Porcupine) RXC007 (ROCK2 selective) Proven drug discovery expertise Exceptional capabilities in medicinal chemistry and translational science are the foundation of Redx. The Company has built an attractive portfolio of assets and has a strong proven track record of drug discovery and development. Over the past three years, it has delivered four major preclinical stage transactions, with further clinical and operational key milestones expected in the future. RXC004 is due to start a phase 2 clinical study in patients with advanced malignancies in H2 2021. The Company’s selective ROCK2 inhibitor, RXC007, also entered a phase 1 clinical study in H1 2021. Latest news 30-Nov-2021 Redx to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference 17-Nov-2021 Redx to Present at Jefferies London Healthcare Conference 15-Nov-2021 Redx Announces First Patient Dosed in Phase 2 Clinical Trial of RXC004 in Patients with Advanced Colorectal Cancer 01-Nov-2021 Redx Announces the Appointment of Dr Jane Griffiths, an Accomplished Pharma Industry Executive and Board Director, as Non-Executive Chair View all news Scientific publications AACR 2021 Poster – Mechanism of action of RXC004, a Wnt pathway inhibitor, in genetically-defined models of cancer ELRIG 2020 Poster – Validation of immune cell analysis in whole blood by flow cytometry for clinical biomarker investigation AACR 2019 – Efficacy of the Wnt/Beta-Catenin pathway inhibitor RXC004 in genetically-defined models of cancer AACR 2019 – Wnt/b-Catenin pathway inhibitor RXC004 enhances the immunity of pre-clinical models of cancer View all scientific presentations Board of Directors Our pipeline Email alerts Redx Copyright © 2021 Redx Pharma Plc Privacy & terms Cookie policy Website design & build by Carr Kamasa Design We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy. I Accept